Financial Statements — IMOS
Balance Sheet
(in billions TWD)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Cash & Equivalents | 15.22 | 0.40 | 9.90 | 5.91 | 0.15 | 0.16 |
| Inventory | 0.08 | 2.57 | 3.21 | 3.21 | 2.10 | 1.77 |
| Total Current Assets | 23.64 | 0.82 | 0.60 | 16.49 | 12.36 | 11.76 |
| Total Non-current Assets | 21.74 | 21.00 | 26.59 | 26.04 | 22.72 | 22.54 |
| Total Assets | 1.38 | 1.51 | 1.46 | 42.52 | 35.08 | 34.31 |
| Total Current Liabilities | 0.27 | 7.44 | 6.49 | 7.41 | 0.20 | 5.02 |
| Total Non-current Liabilities | 11.64 | 0.46 | 13.81 | 10.97 | 0.31 | 9.76 |
| Total Liabilities | 20.38 | 21.40 | 0.66 | 18.38 | 14.36 | 14.78 |
| Retained Earnings | 8.44 | 8.46 | 8.51 | 8.52 | 5.40 | 4.65 |
| Total Stockholder Equity | 25.00 | 24.76 | 24.64 | 24.14 | 20.72 | 19.53 |
Income Statement
(in billions TWD)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Total Revenue | 22.70 | 0.70 | 23.52 | 0.99 | 23.01 | 20.34 |
| Cost of Revenue* | 19.75 | (2.85) | 18.61 | (6.27) | 17.98 | 16.41 |
| Gross Profit | 2.94 | 3.55 | 4.91 | 7.25 | 5.03 | 3.93 |
| Research & Development | 1.16 | 0.04 | 1.16 | 1.14 | 1.02 | 1.01 |
| Total Operating Expenses* | 1.67 | 3.49 | 4.81 | 1.69 | 1.47 | 1.47 |
| Operating Income | 1.27 | 0.06 | 0.10 | 5.56 | 3.57 | 2.46 |
| Interest Expense | 0.28 | 0.27 | 0.14 | 0.12 | 0.16 | 0.17 |
| Pretax Income | 1.65 | 2.27 | 4.03 | 0.22 | 2.97 | 3.02 |
| Tax Provision | 0.01 | 0.30 | 0.59 | 1.10 | 0.59 | 0.51 |
| Net Income | 1.44 | 1.97 | 3.44 | 4.94 | 2.38 | 0.08 |
* Derived from reported values
Cash Flow Statement
(in billions TWD)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Operating Cash Flow | 5.94 | 0.22 | 0.28 | 0.26 | 5.94 | 5.98 |
| Investing Cash Flow | (0.62) | (3.09) | (0.16) | (6.02) | (0.14) | (0.14) |
| Financing Cash Flow | (2.48) | (1.06) | 0.42 | 0.02 | (2.72) | (1.68) |